You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 20, November 25, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Health Agencies Update
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Pediatrics
 •Neonatology and Infant Care
 •Women's Health
 •Pregnancy and Breast Feeding
 •Endocrine Diseases
 •Diabetes Mellitus
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Gestational Diabetes

Bridget M. Kuehn

JAMA. 2009;302(20):2194.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Treating women with mild gestational diabetes may lower the risk of large infants, shoulder dystocia, cesarean delivery, or elevated maternal blood pressure, according to a study funded by Eunice Kennedy Shriver National Institute of Child Health and Human Development.


Figure 90009FA
New findings indicate that women with mild gestational diabetes may benefit from dietary changes, monitoring their blood glucose levels, and, when necessary, taking insulin. (Photo credit: Cordelia Molloy/www.sciencesource.com)

The randomized trial included 958 women who met criteria for mild gestational diabetes who were randomly assigned to a treatment group (dietary intervention, self-monitoring of blood glucose, and insulin when indicated), or to a control group (usual prenatal care) (Landon MB et al. N Engl J Med. 2009;361[14]:1339-1348). There was no significant difference between the groups in the study's primary outcome measure, which was a composite of mortality or morbidities in the infant, including hyperbilirubinemia, hypoglycemia, or . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.